Among 54 patients having RAS wt tumor tissue, 34 were treated with anti-EGFR monoclonal antibodies (31 with cetuximab and 3 with panitumumab-based regimens; 30 plus chemotherapy and 4 in monotherapy). The gene discussed is EGFR; the disease is neoplasm.